| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11474661 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 243 journal articles in the PubMed database | Email to a friend | | |
| Kreitman RJ, Wilson WH, Bergeron K, et al.
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. [Clinical Trial, Journal Article]
N Engl J Med 2001 Jul 26; 345(4):241-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kreitman RJ, Squires DR, Stetler-Stevenson M, et al.
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
J Clin Oncol 2005 Sep 20; 23(27):6719-29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kreitman RJ, Pastan I
Immunobiological treatments of hairy-cell leukaemia. [Journal Article, Review]
Best Pract Res Clin Haematol 2003 Mar; 16(1):117-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Becker SE
The Disease With Hope: Hairy Cell Leukemia. [JOURNAL ARTICLE]
Clin J Oncol Nurs 2007 Aug 1; 11(5):731-735.
Abstract | Full Citation | | Bang S, Nagata S, Onda M, et al.
HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity. [Journal Article]
Clin Cancer Res 2005 Feb 15; 11(4):1545-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Saven A, Burian C, Koziol JA, et al.
Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. [Journal Article]
Blood 1998 Sep 15; 92(6):1918-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kreitman RJ, Pastan I
BL22 and lymphoid malignancies. [Journal Article]
Best Pract Res Clin Haematol 2006 Dec; 19(4):685-99.
Abstract | Full Citation | Find Related Articles | | Kreitman RJ, Wilson WH, Robbins D, et al.
Responses in refractory hairy cell leukemia to a recombinant immunotoxin. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Blood 1999 Nov 15; 94(10):3340-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kreitman RJ, Margulies I, Stetler-Stevenson M, et al.
Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias. [Journal Article]
Clin Cancer Res 2000 Apr; 6(4):1476-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
